Overview

Pain Management in Corneal Collagen Crosslinking for Keratoconus

Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
0
Participant gender:
All
Summary
This is a prospective, randomized, single blind study. Patients enrolled in the study were randomly assigned to a ketorolac or a gabapentin group for pain control. Different pain scores and variables will be evaluated, along with others side effects variables.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Instituto de Oftalmología Fundación Conde de Valenciana
Treatments:
Gabapentin
Ketorolac
Ketorolac Tromethamine
Criteria
Inclusion Criteria:

- Patients with keratoconus older than 18 years with documented bilateral keratometric
progression in the previous 6 to 12 months.

Exclusion Criteria:

- Previous ocular or systemic diseases that could affect epithelial healing; use of
topical or systemic non-steroidal anti-inflammatory drugs, or chronic use of any other
pain medication, pregnancy and allergy to the drugs of the study.